STP938, a Novel, Potent and Selective Inhibitor of CTP Synthase 1 (CTPS1) Is a Targeted Therapy Specifically Blocking De Novo Nucleotide Synthesis in Lymphomas and Leukemias
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:31-31 - Subject
- Language
- ISSN
- 0006-4971